Mairs & Power Inc’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Mairs & Power Inc’s Portfolio NWBO Stock Details NWBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-12,500	Closed	-$2K	–	210
2020 Q1	$2K	Hold	12,500	–	–	﹤0.01%	198
2019 Q4	$3K	Hold	12,500	–	–	﹤0.01%	220
2019 Q3	$3K	Hold	12,500	–	–	﹤0.01%	214
2019 Q2	$3K	Hold	12,500	–	–	﹤0.01%	217
2019 Q1	$3K	Hold	12,500	–	–	﹤0.01%	212
2018 Q4	$3K	Hold	12,500	–	–	﹤0.01%	200
2018 Q3	$2K	Hold	12,500	–	–	﹤0.01%	216
2018 Q2	$3K	Hold	12,500	–	–	﹤0.01%	213
2018 Q1	$3K	Hold	12,500	–	–	﹤0.01%	202
2017 Q4	$3K	Hold	12,500	–	–	﹤0.01%	198
2017 Q3	$2K	Hold	12,500	–	–	﹤0.01%	200
2017 Q2	$2K	Hold	12,500	–	–	﹤0.01%	198
2017 Q1	$3K	Hold	12,500	–	–	﹤0.01%	202
2016 Q4	$4K	Hold	12,500	–	–	﹤0.01%	188
2016 Q3	$7K	Hold	12,500	–	–	﹤0.01%	193
2016 Q2	$7K	Hold	12,500	–	–	﹤0.01%	188
2016 Q1	$18K	Hold	12,500	–	–	﹤0.01%	187
2015 Q4	$40K	Buy	+12,500	New	+$60.1K	﹤0.01%	188

Other funds holding NWBO

WJWM

Williams Jones Wealth Management New York $8.86B AUM 22.16% 1-Year Est. Return

MSAM

Moloney Securities Asset Management Manchester, Missouri $840M AUM 18.11% 1-Year Est. Return

LDB

Lee, Danner & Bass Nashville, Tennessee $1.73B AUM 36.69% 1-Year Est. Return

OCG

Opus Capital Group Cincinnati, Ohio $1.03B AUM 20.67% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return

Mairs & Power Inc's NWBO Position: Q2 2020 in Review

Mairs & Power Inc sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q2 2020, closing a stake of 12,500 shares — an estimated $2K sold.

Mairs & Power Inc first reported a position in NWBO in Q4 2015 and held it in 18 quarters. The position peaked at $40K in Q4 2015. 5 funds tracked by Wall St. Rank hold NWBO as of Q2 2020.

Mairs & Power Inc reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q2 2020 after selling out during the quarter.
Mairs & Power Inc sold 12,500 Northwest Biotherapeutics, Inc. Common stock shares in Q2 2020, an estimated $2K.
Mairs & Power Inc first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q4 2015 and held it in 18 quarters.
Mairs & Power Inc's Northwest Biotherapeutics, Inc. Common stock position peaked at $40K in Q4 2015.
5 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q2 2020.

Based on Mairs & Power Inc's 13F filing for Q2 2020, filed 14 Aug 2020.